3DDS: Alzheimer’s Disease Drug Discovery in 3-D

2015, 2016

We propose to examine biological fluids from cells treated with individual drugs that have been approved previously by the U.S. Food and Drug Administration for the treatment of numerous diseases and disorders. We will determine whether these drugs reduce the levels of the toxic proteins known to cause Alzheimer’s disease. Newly identified drugs or similar modified compounds will be developed as Alzheimer’s therapeutics.

Funding to Date



Drug Discovery, Drug Screening Projects


Weiming Xia, Ph.D.